188 studies found for:
"Diabetic Nephropathies"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 21 | Completed |
Adiponectin and Insulin Resistance in Diabetic Nephropathy
|
||||
| 22 | Completed |
Effect of Pyridorin in Patients With Diabetic Nephropathy
|
||||
| 23 | Completed |
Effect of Pyridorin in Patients With Diabetic Nephropathy
|
||||
| 24 | Not yet recruiting |
Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy
|
||||
| 25 | Recruiting |
Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy
|
||||
| 26 | Completed |
Evaluating the Renoprotective Effect of Milk Thistle Extract on Patients With Type II Diabetic Nephropathy
|
||||
| 27 | Unknown † |
Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney Disease
|
||||
| 28 | Active, not recruiting |
Combined Diabetes-Renal Multifactorial Intervention In Patients With Advanced Diabetic Nephropathy (ADN)
|
||||
| 29 | Unknown † |
Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study
|
||||
| 30 | Recruiting |
Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients
|
||||
| 31 |
Completed
Has Results |
ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial
|
||||
| 32 | Completed |
To Assess the Accuracy of the eZscan Study in the Screening for Diabetic Nephropathy
|
||||
| 33 |
Completed
Has Results |
Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy
|
||||
| 34 | Completed |
Effect of Dietary Protein Restriction on Prognosis in Patients With Diabetic Nephropathy
|
||||
| 35 | Active, not recruiting |
Low Protein Diet Supplemented With Ketoanalogs on Reducing Proteinuria and Maintaining Nutritional Status in Type 2 Diabetic Nephropathy
|
||||
| 36 | Recruiting |
A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria
|
||||
| 37 |
Completed
Has Results |
The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors
|
||||
| 38 | Recruiting |
A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR
|
||||
| 39 | Completed |
Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus
|
||||
| 40 | Terminated |
Effect of Low Protein Diet in Preventing the Progression of Diabetic Nephropathy
|
† Indicates status has not been verified in more than two years

